Using Mixed Lineage Leukemia Inhibitors to Treat Neuroendocrine Tumors

TECHNOLOGY NUMBER: 6964
Technology No. 6964
MOUSE
1

INNOVATION

This invention provides a VillinCre:Men1FL/FL;Sst-/- mouse line. This mouse line can be used to test the efficacy of Menin-MLL inhibitors in treating the endocrine tumors and elevated gastrin levels due to the mutation in Men1.

  • swap_vertical_circlemode_editInventor (1)
    Juanita Merchant
  • swap_vertical_circlecloud_downloadSupporting documents (1)
    Product brochure
    Using Mixed Lineage Leukemia Inhibitors to Treat Neuroendocrine Tumors.pdf
    DOWNLOAD
Questions about this technology?
Contact us